1-103536187-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_017619.4(RNPC3):c.617C>T(p.Pro206Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00137 in 1,534,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 1 hom. )
Consequence
RNPC3
NM_017619.4 missense
NM_017619.4 missense
Scores
3
7
8
Clinical Significance
Conservation
PhyloP100: 6.99
Genes affected
RNPC3 (HGNC:18666): (RNA binding region (RNP1, RRM) containing 3) Two types of spliceosomes catalyze splicing of pre-mRNAs. The major U2-type spliceosome is found in all eukaryotes and removes U2-type introns, which represent more than 99% of pre-mRNA introns. The minor U12-type spliceosome is found in some eukaryotes and removes U12-type introns, which are rare and have distinct splice consensus signals. The U12-type spliceosome consists of several small nuclear RNAs and associated proteins. This gene encodes a 65K protein that is a component of the U12-type spliceosome. This protein contains two RNA recognition motifs (RRMs), suggesting that it may contact one of the small nuclear RNAs of the minor spliceosome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.076382786).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000723 (110/152166) while in subpopulation NFE AF= 0.00135 (92/67974). AF 95% confidence interval is 0.00113. There are 0 homozygotes in gnomad4. There are 37 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNPC3 | NM_017619.4 | c.617C>T | p.Pro206Leu | missense_variant | 6/15 | ENST00000423855.7 | NP_060089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNPC3 | ENST00000423855.7 | c.617C>T | p.Pro206Leu | missense_variant | 6/15 | 1 | NM_017619.4 | ENSP00000391432 | P4 | |
RNPC3 | ENST00000533099.5 | c.617C>T | p.Pro206Leu | missense_variant | 7/16 | 5 | ENSP00000432886 | P4 | ||
RNPC3 | ENST00000524631.5 | c.617C>T | p.Pro206Leu | missense_variant | 6/15 | 2 | ENSP00000437278 | A1 | ||
RNPC3 | ENST00000527062.5 | c.140C>T | p.Pro47Leu | missense_variant | 6/8 | 5 | ENSP00000436315 |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152048Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
110
AN:
152048
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000551 AC: 78AN: 141604Hom.: 0 AF XY: 0.000555 AC XY: 42AN XY: 75734
GnomAD3 exomes
AF:
AC:
78
AN:
141604
Hom.:
AF XY:
AC XY:
42
AN XY:
75734
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00144 AC: 1988AN: 1382652Hom.: 1 Cov.: 28 AF XY: 0.00136 AC XY: 926AN XY: 682372
GnomAD4 exome
AF:
AC:
1988
AN:
1382652
Hom.:
Cov.:
28
AF XY:
AC XY:
926
AN XY:
682372
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000723 AC: 110AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74398
GnomAD4 genome
AF:
AC:
110
AN:
152166
Hom.:
Cov.:
32
AF XY:
AC XY:
37
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
6
ExAC
AF:
AC:
6
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.617C>T (p.P206L) alteration is located in exon 1 (coding exon 1) of the RNPC3 gene. This alteration results from a C to T substitution at nucleotide position 617, causing the proline (P) at amino acid position 206 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;T;D;T
Polyphen
0.90
.;P;.;P
Vest4
MVP
MPC
0.44
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at